Nitric oxide donor sodium nitroprusside induces neurotoxicity in cerebellar granular cell culture in rats by an independent mechanism from L-type or dantrolene-sensitive calcium channels

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 10, 2002, Pages 1295-1297

  Gepdiremen, Akçahan ^a   Hacimüftüoǧlu, Ahmet ^a   Büyükokuroǧlu, Mehmet Emin ^a   Süleyman, Halis ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Cell culture; Cerebellum; Dantrolene; Neurotoxicity; Nimodipine; Sodium nitroprusside

Indexed keywords

CALCIUM CHANNEL L TYPE; DANTROLENE; NIMODIPINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NITRIC OXIDE DONOR;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CEREBELLUM; GRANULAR CELL; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT; ANIMAL; CELL CULTURE; CELL DEATH; CYTOLOGY; DRUG EFFECT; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CALCIUM CHANNELS, L-TYPE; CELL DEATH; CELLS, CULTURED; CEREBELLUM; DANTROLENE; NITRIC OXIDE DONORS; NITROPRUSSIDE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036782446     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.1295     Document Type: Article

References (24)

1. Iadecola C., Trends Neurosci., 20, 132-139 (1997).
2. Clementi E., Vecchio I., Corasaniti M. T., Nistico G., Eur. J. Pharmacol., 289, 113-123 (1995).
3. Heales S. J., Bolanos J. P., Land J. M., Clark J. B., Brain Res., 668, 243-245 (1994).
4. McDonald L. J., Moss J., Proc. Natl. Acad. Sci. U.S.A., 90, 6238-6241 (1993).
5. Drapier J. C., Hirling H., Wietzerbin J., Kaldy P., Kuhn L. C., EMBO J., 12, 3643-3649 (1993).
6. Zhang J., Dawson W. L., Dawson T. M., Snyder S. H., Science, 263, 687-689 (1994).
7. Ermak G., Davies K. J., Mol. Immunol., 38, 713-721 (2002).
8. Clapham D. E., Cell, 80, 259-268 (1995).
9. McConkey D. J., Orrenius S., J. Leukocyte Biol., 59, 775-783 (1996).
10. Henschke P. N., Elliot S. J., Biochem. J., 312, 485-489 (1995).
11. Xu J., Wojcik W. J., J. Pharmacol. Exp. Ther., 239, 568-573 (1985).
12. Rauhala P., Khaldi A., Mohanakumar K. P., Chiueh C. C., Free Rad. Biol. Med., 24, 1065-1073 (1998).
13. Lin S., Zhang Y., Dodel R., Farlow M. R., Paul S. M., Du Y., Neurosci. Lett., 315, 61-64 (2001).
14. Salom J. B., Orti M., Centeno J. M., Torregrosa G., Alborch E., Brain Res., 865, 149-156 (2000).
15. Mohanakumar K. P., Hanbauer I., Chiueh C. C., J. Chem. Neuroanat., 14, 195-205 (1998).
16. Gepdiremen A., Sönmez S., Batat I., Eşrefoǧlu M., Düzenli S., Süleyman H., Fundam. Clin. Pharmacol., 11, 117-120 (1997).
17. Zhang X. Q., Watanabe Y., Ohnishi M., Baba T., Shibuya T., Jpn. J. Pharmacol., 62, 411-414 (1993).
18. Rapoport T. A., Science, 258, 931-936 (1992).
19. Berridge M. J., Biochem. J., 312, 1-11 (1995).
20. Chang J. Y., Korolev V. V., Exp. Neurol., 137, 201-211 (1996).
21. Frandsen A., Schousboe A. J. Neurochem., 56, 1075-1078 (1991).
22. Mehendale H. M., Roth R. A., Gandolfi A. J., Klaunig J. E., Lemasters J. J., Curtis L. R., FASEB J., 8, 1285-1295 (1994).
23. Gepdiremen A., Düzenli S., Hacimüftüoǧlu A., Süleyman H., Öztaş S., Pharm. Res., 43, 241-244 (2001).
24. Kashii S., Mandai M., Kikuchi M., Honda Y., Tamura Y., Kaneda K., Akaike A., Brain Res., 711, 93-101 (1996).